GlassScriptPhysician profile
Aidan Bennardo
NPI 1205332145
$2,638.32
in general payments reported to CMS, 2019-2025
30 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $264 · 2022: $447 · 2023: $815 · 2024: $684 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,927.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $494.85 | 2021-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $372.88 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $346.08 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $345.26 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Abbvie INC. | $153.80 | 2022-2024 | Synthroid, Ubrelvy |
| Edwards Lifesciences Corporation | $140.00 | 2023 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $109.31 | 2021-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.83 | 2022-2024 | Xifaxan, Trulance |
| Amgen INC. | $60.44 | 2022-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.14 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $52.58 | 2023 | Dificid |
| Exact Sciences Corporation | $48.65 | 2023 | Cologuard Collection Kit |
| Eisai INC. | $45.86 | 2023-2024 | |
| Inspire Medical Systems, INC. | $34.90 | 2025 | Inspire |
| Seqirus USA INC | $34.60 | 2022-2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $28.59 | 2022 | |
| Novavax INC | $26.39 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Renalytix Ai, INC. | $24.50 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Dexcom, INC. | $22.58 | 2022 | |
| Axsome Therapeutics, INC. | $19.48 | 2022 | |
| Phathom Pharmaceuticals, INC. | $19.44 | 2024 | Voquezna |
| Novartis Pharmaceuticals Corporation | $18.16 | 2022 | |
| Shield Therapeutics INC | $17.71 | 2023 | Accrufer |
| Philips North America LLC | $16.66 | 2024 | (Ck7) Extended Holter |
| Xeris Pharmaceuticals, INC. | $15.12 | 2025 | Keveyis |
| Ardelyx, INC. | $15.05 | 2024 | Ibsrela |
| Phadia US INC. | $14.01 | 2024 | Immunocap |
| Pfizer INC. | $13.89 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.43 | 2023 | Gattex |
| Esperion Therapeutics, INC. | $13.13 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aidan Bennardo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.